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Endothelialdysfunctionandasedentarylifestylemaybeinvolved inthedevelopment ofhypertensionwhichisproliferativeamong
middle-aged African Americans (AA). Signaling molecules derived from the oxidation of 20-carbon fatty acid molecules known
as eicosanoids inﬂuence vascular tone. The relationship between aerobic ﬁtness and eicosanoid formation following exercise
in middle-aged African American hypertensives is unknown. Purpose. To determine the relationship between aerobic capacity
and eicosanoid formation after a bout of moderate-intensity exercise in middle-aged AA hypertensives. Methods. Ten sedentary
hypertensive AA underwent 50min of aerobic exercise at 65% VO2max. Urine was collected for 24 hr on two occasions, prior to
testing and immediately following the bout of exercise. Urinary metabolites of prostacyclin (6-keto PGF1α) and thromboxane (11-
dTXB2) were measured during the day and night periods by high-performance liquid chromatography (HPLC). Results.6 - k e t o
PGF1α levels signiﬁcantly increased (P = .04) following the bout of exercise compared to the control day. There was a signiﬁcant
relationship (r = .49, P<. 05) between 6-keto PGF1α levels and VO2max during the exercise day. Conclusion. Based on this
preliminary study, there appears to be a relationship between aerobic capacity and exercise-induced 6-keto PGF1α production in
middle-aged hypertensive AAs. AAs with lower VO2max had lower 6-keto PGF1α formation.
1.Introduction
Hypertension is a multifactorial disease that has high preva-
lence in African Americans [1, 2]. National surveys show
that the majority of middle-aged, urban African Americans
engage in little or no leisure-time physical activity [3]. This
high prevalence of physical inactivity contributes to the
disproportionate burden of obesity, hypertension, diabetes,
and coronary heart disease in African Americans [3–5].
A number of important causal factors for hypertension
have been identiﬁed. Research has implicated endothelial
dysfunction as a factor involved in the pathogenesis of
hypertension and is evident in the early stages of the
development of coronary atherosclerosis [1, 6–9]. Hyper-
tension is also more prevalent with advancing age. The
prevalence of endothelial-impaired function disorders such
as hypertension is disproportionately higher in the African
American population in contrast to Caucasians [1, 2, 10].
Eicosanoids are 20-carbon molecules derived from
arachidonic acid, a polyunsaturated fatty acid. Cyclooxyge-
nase 1 or 2 (COX-1 or COX-2) and cell-speciﬁc synthases
convert free arachidonic acid to a biologically active com-
pound. The biologically active eicosanoid binds to receptors
on the target cell plasma membrane to cause a wide range
of biologic eﬀects including platelet aggregation, lymphocyte
aggregation and proliferation, bronchoconstriction, and
vasodilation or vasoconstriction. Stable metabolites of the
eicosanoids can be measured in urine, plasma, or tissue and
arethoughttorepresentwhole-body synthesis ofeicosanoids
[11, 12].2 Journal of Aging Research
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Thromboxane (TXA2), a vasoconstrictor and platelet
aggregator, and prostacyclin (PGI2), a vasodilator and
antiplatelet aggregator, are the most well-characterized
eicosanoids inﬂuencing vascular tone. TXA2, a very unstable
compound produced by platelets, has thrombogenic prop-
erties and is cytotoxic. The stable metabolite of TXA2 is 11-
dehydro-thromboxaneB2 (11-dTXB2).Thestablemetabolite
of PGI2 is 6-keto PGF1α.
Acuteexerciseenhancesthegenerationofreactiveoxygen
species (ROS) which can lead to the oxidation of lipids,
proteins, and nucleic acids altering cellular function. The
increase in ROS after acute exercise promotes an acute phase
of local inﬂammation that characteristically induces the
release of inﬂammatory cytokines. These cytokines stimulate
the release of arachidonic acid and ultimately an increase
in PGI2 production. Thus, the exercise-induced increase in
PGI2 is a normal consequence following exercise [13, 14]. A
recent study by Zoladz reported an attenuated PGI2 release
following exercise in coronary artery disease and hyperten-
sive patients when compared to healthy controls [15]. There
is contrasting evidence reported on exercise-induced TXA2
production. Some research indicates an increase in TXA2
following exercise when others have reported no change [15–
19].
There is little, if anything, known about the acute
exercise-induced responses of PGI2 and TXA2 in middle-
aged African Americans. The purpose of the study was to
assess the changes, if any, in PGI2 and TXA2 production
following a single bout of aerobic exercise in middle-aged
hypertensive African Americans.
2. Protocol
2.1. Participants. Participants were recruited from the Balti-
more,MDandWashington,DCarea.Tenvolunteers(5male,
5f e m a l e ;5 8±2.3yrs) completed the study. The participants
were sedentary (regular aerobic exercise ≤2sessions/wk and
<20min/session, sedentary occupation) African Americans
who were categorized as having prehypertension (pre-HTN)
or stage 1 hypertension (systolic and diastolic blood pressure
(BP) 143 ±7/87 ±7mmHg).
2.2. Screening. Subjects had a physical examination, routine
fasting blood chemistries, and BP measured under standard-
ized conditions. Inclusion criteria required participants to
be pre- or stage 1 hypertensive according to the Seventh
Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pres-
sure (JNC 7) guidelines [2] having an average systolic BP of
120–139mmHg (pre-HTN), 140–159mmHg (stage 1), and
a diastolic BP of 80–89mmHg (pre-HTN), or 90–99mmHg
(stage 1). No participants were taking antihypertensive
medications. BP level was determined by the average of three
casual BP readings from three separate days according to
the standards established by the JNC 7 guidelines. Blood
samples were drawn in the morning following a 12-hour
fast and sent to Quest Diagnostics for routine chemistries.
In addition, blood lipids, serum creatinine, and glucose
were also measured. Blood lipids were assessed to rule out
hyperlipidemia; serum creatinine was measured to rule out
renal dysfunction; fasting glucose was measured to rule
out diabetes. Individuals with abnormal blood chemistries
were excluded from further participation in the study. Each
participant then underwent a physical examination by the
study physician. Exclusion criteria included smoking, a body
mass index (BMI) >35, alcohol intake of more than 3
drinks per day, diabetes (fasting glucose level >126mg/dL),
total cholesterol >240mg/dL, and evidence of renal or
cardiovascular disease.
The screening GXT was a maximal test to screen for
signs and symptoms of coronary artery disease. During the
test, the participants walked on a treadmill while their blood
pressure, heart rate, and ECG response were monitored. The
speed and/or degree of incline of the treadmill increased
every 3 minutes until the participants could no longer con-
tinue or showed signs or symptoms of cardiovascular events.
Participants having a negative screening graded exercise
stress test (GXT) were excluded from further participation
in the study. The study protocol was approved by the
Institutional Review Board of the University of Maryland,
College Park. Informed consent was obtained from each
participant. A timeline of the protocol is provided in Table 1.
2.3. 24-Hour Urine Collection. Urine was collected for a 24-
hourperiodoneweekpriortotheexercisesession(Baseline).
Samples were collected in ﬁve time periods (00:00–08:00,
08:00–12:00, 12:00–16:00, 16:00–20:00, and 20:00–0:00).
Urine for each time period was collected in a separate
container. All urine collection containers were kept on ice
in a cooler for the entire 24-hour period. Subjects began
urine collection after their ﬁrst void in the morning and
endedaftertheirﬁrstvoidthefollowingmorning.Totalurine
volume was measured to the nearest .5mL and an aliquot
of the pooled 24 hour urine was sent to Quest Diagnostics
for determination of creatinine concentration. Creatinine is
a breakdown product of creatine phosphate in muscle. InJournal of Aging Research 3
the absence of kidney dysfunction, creatinine clearance is
relatively constant and can be used as a means to compare
other excreted metabolites. Aliquots from each time period
were frozen at −80◦C until analysis. A second 24-hour urine
collection was repeated immediately following the exercise
session.
2.4. Diet. Three days prior to beginning baseline testing,
subjects were instructed to maintain their usual diets and
complete a 6-day dietary log. Each subject was given their
dietary information recorded during the baseline period and
instructed to repeat the 6-day diet leading to the exercise day.
2.5. Graded Exercise Test to Measure Aerobic Capacity. A
second GXT was completed a week prior to the exercise
session. All subjects completed a maximal treadmill exercise
test to derive a valid prescription for the acute exercise
session. When oxygen consumption (VO2)i sa d d e dt o
aG X T ,i ti sp o s s i b l et om e a s u r eV O 2max, an index of
cardiovascular ﬁtness. Participants began at 70% of the peak
heartrateachievedonthesubject’sscreeningexercisetestand
the treadmill grade was increased 2% every 2 minutes. Blood
pressure, heart rate, and ECG were monitored during the
test which was terminated when the subject could no longer
continue. VO2 was measured continuously throughout this
test using a mass spectrometer (Marquette), mixing chamber
(Rayﬁeld), turbine volume meter system (model VMM,
Interface Associates), and customized validated metabolic
software. Standard criteria were used to determine if
VO2max had been achieved. Subjective criteria included
the subject’s rating of their perceived exertion and their
physical inability to continue exercise. The objective criteria
that were monitored were a plateau in rise in heart rate
and a respiratory exchange ratio of greater than 1.15. The
respiratory exchange ratio is determined by dividing the
volume of CO2 expired per minute by the volume of O2
inspired per minute.
2.6. Acute Exercise Session. The goal of the exercise session
was to accumulate 50 minutes of exercise. The exercise
session began with a 10-minute warm-up consisting of
walking and stretching exercises. The participants then
walked on a treadmill for 30 minutes, followed by 5 minutes
of rest, and then 20 additional minutes of treadmill walking
or cycle ergometry for a total of 50 minutes of submaximal
exercise. A heart rate monitor (Polar CIC, Inc.) was used to
ensure that each subject’s exercise heart rate corresponded to
65% of their aerobic capacity that was measured during the
VO2max GXT. After completing the acute exercise session,
participants began a 24-hour urine collection period in the
same manner as during the baseline collection.
2.7. Measurement of 6-Keto PGF1α and 11-dTXB2
2.7.1. Chemicals and Materials. The prostaglandins (6-keto
PGF1α and 11-dTXB2) were purchased from Biomol (Ply-
mouth meeting, PA, USA). Creatinine was purchased from
Sigma-Aldrich (St. Louis, MO, USA). Ortho Phosphoric
acid, HPLC water, and acetonitrile were purchased from
Fisher Scientiﬁc (Waltman, MA, USA).
2.7.2. Instrumentation. The Jasco HPLC system consisted
of a Jasco pumps (PU-980), a Jasco UV-VIS detector
(UV-975; Jasco Incorporated Easton, MD, USA), and a
Rheodyne manual injector (Rheodyne LLC, Rohnert Park,
CA, USA). Jasco-Borwin software (version 3.3.5) was used
for data collection. The analysis was done on a Symmetry
C18 4.6 × 250mm column with 5μmp a r t i c l es i z e( W a t e r s
Corporation, Milford, MA, USA).
2.7.3. HPLC Method. Acetonitrile was used as the organic
phase. Phosphoric acid solution (pH = 4) was used as
the aqueous phase as it gave much better chromatographic
results than acetic acid solution. An acidic solution (pH of
4) was necessary to maintain the eicosanoids in the neutral
state. Creatinine, at pH = 4 which is below its pKa value
(4.83) will be in the protonated form. Creatinine in this form
will be retained for a very short period of time on a nonpolar
stationaryphasecomparedtotheneutralformof8-isoPGF2,
a long-chain (C20) polyunsaturated fatty acid. The ﬂow rate
and ratio of the aqueous and organic phase were selected
to obtain a method with a practical run time and which
resulted in good separation of all the compounds. All the
chromatograms showed a negative drop at around 3.0min.
This is due to the change in the wavelength from 254nm to
196nm. The HPLC method employed an isocratic elution of
17mM phosphoric acid (solvent A) and acetonitrile (solvent
B) in the ratio of 65:35. The analytes were separated at
ambienttemperaturewithaninjection volumeof100μLand
usingaﬂowrateof1.3mL/min.Theruntimeforthemethod
was 16.5min.
Urinary metabolites 6-keto PGF1α and 11-dTXB2 were
dissolved in 1mL methanol such that the stock mass
concentration for all was 1mg/mL. 1000mg of creatinine
was dissolved in 100mL HPLC water to obtain a stock
having concentration of 10mg/mL. Working standards for
the analytes were prepared by serial dilution using 17mM
phosphoric acid and acetonitrile in the ratio of 1:1 as the
solvent. The solutions were stored at −80◦Cw h e nn o ti nu s e .
75μL of the ﬁltered urine samples was diluted to 500μLwi t h
a 1:1 mixture of 17mM phosphoric acid and acetonitrile
before injecting into the HPLC system.
2.7.4. Linearity, Accuracy, and Precision and Recovery. The
HPLC method was validated as per the FDA guidance for the
industry: bioanalytical method validation [20]. The linear
range for 6-keto PGF1α and 11-dTXB2, the metabolites of
arachidonic acid, was established by injecting in triplicate
standardsolutionsatmassconcentrationsrangingfromtheir
respective LOQ to 1000ng. Both the compounds showed
a good linear response with R2 > 0.999 in the range.
Accuracy was determined by analyzing the compounds at
three diﬀerent mass concentration levels. Percent accuracy
for the prostanoids was between 90.3–101.5%. Interassay
and intra-assay precision were determined by injecting in
triplicate. Intra-assay and interassay precision as indicated4 Journal of Aging Research
Table 2: Baseline demographic and clinical characteristics.
Male/female 5/5
Age (years) 58 ±2.3
BMI (kg/m2)3 0 .5 ±1.1
VO2 (mL/kg/min) 22.6 ±1.2
TC (mg/dL) 214.8 ±9.2
LDL-C (mg/dL) 131.8 ±10.1
VLDL-C (mg/dL) 27.9 ±4.0
HDL-C (mg/dL) 55.1 ±3.4
Casual Avg SBP (mmHg) 143 ±7
Casual Avg DBP (mmHg) 87 ±7
Values shown as mean ±SEM.
BMI indicates body mass index; VO2, aerobic capacity; TC, total cholesterol;
LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density
lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; SBP,
systolic blood pressure; DBP, diastolic blood pressure.
by the percent relative standard deviation (RSD) were
<10%. The percent recovery for the prostanoids at the three
concentration levels was within 95–108%.
Instrument precision was determined by injecting a
single mixture containing all the compounds six times and
calculating the RSD values. RSD values were found to be
less than 5% for all the analytes. The RSD values for all
injections were <10% for intra-assay precision, and all urine
metabolites were normalized to ug of creatinine.
3. Statistics
For statistical analyses, we redeﬁned the time periods to AM
(08:00–16:00) and PM (16:00–00:00) because of insuﬃcient
data collected between 00:00–08:00. Descriptive statistics
were performed for subject characteristics and are presented
as mean ± SEM in Table 2. For each urinary metabolite (6-
keto PGF1α and 11-dTXB2), a repeated measures ANOVA
comparing groups at the two time periods; before and after
acute exercise bout. Repeated measures ANCOVA was used
to covary for age, BMI, and aerobic ﬁtness. Separate simple
linear regression analyses were performed with VO2max as
the independent variable and each of the urinary metabolites
as the dependent variables. Values are presented as mean ±
SEM. A value of P ≤ .05 was considered statistically sig-
niﬁcant. Statistical analysis was performed using STATVIEW
(SAS Institute, Cary, NC).
4. Results
Subject characteristics are shown in Table 2.T e nA f r i c a n
American men and women (5 male, 5 female), age 58 ±
2.3 years, participated in the study. VO2max determined
from the GXT ranged from 17.4–29.3mL/kg/min (mean
22.6 ± 1.2mL/kg/min), which would classify all participants
as sedentary. The average LDL-C for the participants was
131.8 ± 10.1, which is borderline high according to the
American Heart Association guidelines.
Final
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Figure 1: Urinary 6-keto PGF1α levels increased from 33.5 ±
11ng/ug to 77.8 ± 14.1ng/ug during the AM period after the
bout of exercise when compared to baseline. Levels returned to
near baseline during the PM collection following the exercise bout,
∗P<. 05.
The urinary metabolites were examined at two time peri-
ods: 08:00–16:00 (AM) and 16:00–00:00 (PM) by ANOVA.
Baseline levels of 6-keto PGF1α and 11-dTXB2 were 33.5 ±
10.9ng/ug and 50.8 ± 20.4ng/ug in the AM, respectively. 6-
keto PGF1α levelsincreasedbymorethattwofoldfrom33.5±
10.9ng/ug at baseline to 77.8±14.1ng/ug (P<. 05; Figure 1)
during the AM collection period after the acute exercise
session. ANCOVA using VO2max as the only covariate,
followed by Fisher’s PLSD, improved the eﬀect of the acute
exercise bout (P = .03). Based on regression analysis,
there was a signiﬁcant relationship (P = .04) between 6-
keto PGF1α levels and VO2max during the AM collection
period following exercise (Figure 2). Regression analysis also
identiﬁed VO2max as a signiﬁcant predictor of 6-keto PGF1α
following the exercise bout.
Correlational analysis conducted using the baseline val-
ues revealed a signiﬁcant positive relationship (r = .97, P =
.04 AM collection; r = .99, P = .01 PM collection) between
LDL-C and 11-dTXB2. This relationship was not observed
between LDL-C and 6-keto PGF1α. Analysis also revealed a
signiﬁcant negative correlation between 6-keto PGF1α levels
and age (r =− .92, P = .003).
The urinary 11-dTXB2 concentrations were decreased
at both collection times; 51% AM and 35% PM relative to
baseline levels; however, this trend, though reproducible and
consistent throughout the study, did not meet the test of
signiﬁcanceasdeﬁnedbyP ≤ .05followingtheacuteexercise
session.
5. Discussion
Increases in vascular shear stress and mobilization and
activation of cytokines and immune cells occur as a result
of exercise. This leads to arachidonic acid liberation from
the plasma membrane. COX-1 or COX-2 and cell-speciﬁcJournal of Aging Research 5
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Figure 2: 6-keto PGF1α measured in urine collected in the
AM following a moderate intensity exercise bout was found to
signiﬁcantly correlate with VO2max in sedentary African American
pre- and stage 1 hypertensives (r = .67, P<. 05).
synthases convert the free arachidonic acid to a biologically
active compound with cytoprotective properties.
Platelet activation increases during exercise. It has been
suggested that metabolic activity in the arachidonic acid
cascade may be increased equally at various exercise intensity
levels, but that the synthesis of PGI2 and TXA2 may be more
heavily inﬂuenced by the exercise intensity level [16]. Alter-
natively, the conversion of arachidonic acid to eicosanoids
otherthanPGI2 andTXA2 maybeaﬀectedbyexercise,which
may be responsible for the observed decrease in 11-dTXB2
following the acute exercise bout. The increase in PGI2
generation could be compensating for the prothrombotic
environment induced by exercise. Prostacyclin production is
initiated by an inﬂux of calcium into the cytoplasm resulting
from the emptying of intracellular stores, which occurs only
in the initial minutes of cellular activation [21]. This could
explain why the increase in the excretion of 6-keto PGF1α
occurred in the morning following the exercise bout and not
later in the day.
Rodrigo et al. reported that blood antioxidant activity
was lower in hypertensives when compared to normotensive
controls [22]. Acute exercise enhances the generation of
ROS, which can lead to the oxidation of lipids, proteins
and, nucleic acids leading to altered cellular function.
ROS increases the expression of antioxidant enzymes, but
this is attenuated in hypertensives [23, 24]. It has been
documentedthat,inahypertensivepopulation,plasmalevels
of 6-keto PGF1α were signiﬁcantly lower than those of
healthy controls [21]. In the current study, individuals who
were more aerobically ﬁt (assessed by VO2max) produced
higher concentrations of urinary 6-keto PGF1α following
an acute bout of exercise. This may suggest that there is
greater antioxidant activity in those individuals who are
more aerobically ﬁt than those who are less aerobically
ﬁt.
Laustiola et al. and Carter et al. observed that plasma
levels of 6-keto PGF1α increased following a low-intensity
(30–50% VO2max) bout of exercise, which suggests that
exercise at lower intensities may stimulate a greater produc-
tion of 6-keto PGF1α [16]. This trend was seen in the present
study population with a 1.5-fold to 2-fold increase in 6-keto
PGF1α. Todd et al. showed that 6-keto PGF1α levels decreased
incrementally as exercise intensity increased to near maximal
levels [16]. In the present study, moderate intensity aerobic
exercise increased urinary levels of 6-keto PGF1α following
exercise in the AM urine sample. This is consistent with
ﬁndings by Okahara et al. that have documented an increase
in 6-keto PGF1α production as a result of increased vascular
shear stress and cytokine release [25]. The 6-keto PGF1α
levels during the PM sample were not diﬀerent than the
baseline day.
Tokunga et al. demonstrated an age-related decline
in PGI2 synthesis which is consistent with our ﬁndings.
Reduced PGI2 production, as a result of aging or selective
COX-2 inhibition, has been proposed as a mechanism
involved in the atherogenic process, myocardial infarctions,
and stroke [26, 27]. Nicholson et al. reported that forearm
vasodilation responses to PGI2 were signiﬁcantly impaired
in an older group when compared to a younger group
matched for BMI and sex. They further suggested age-
related diﬀerences in PGI2-mediated vasodilation are likely
attributed to a reduced contribution of the endothelium-
derived relaxing factor, nitric oxide (NO) [27]. In a race
comparison study, healthy African Americans demonstrated
blunted NO-mediated vasodilation when compared to a
group of healthy Caucasians supporting evidence of race-
related defects in endothelial function [10].
The highly reactive oxygen radical, superoxide anion
(O2
−)h a sah i g ha ﬃnity for NO, which increases the
likelihood of the inactivation of NO and the formation
of peroxynitrite (ONOO−), a potent oxidant [28, 29].
Kalinowksi et al. reported racial diﬀerences in the steady-
state NO/O2
−/ONOO− balance in endothelial cells from
African Americans. Basal levels are reportedly closer to
the redox states characteristic for endothelium-impaired
function disorders [1]. In the current study, LDL-C was
highly correlated with the urinary metabolite 11-dTXB2 at
baseline. LDL-C hasbeen reported toincrease the generation
of O2
−, along with NO. Weisser et al. showed that LDL-
C increases thromboxane synthesis in a dose-dependent
manner [30]. Kuklinska et al. reported a signiﬁcant negative
correlation between LDL-C and PGI2 but we did not observe
such a ﬁnding [6].
Decreases of 11-dTXB2 following the exercise session
could be due to arachidonic acid being used as a precursor
for prostacyclin to compensate for the prothrombotic state.
TXA2 synthase may be at the same expression level, but
competing PGI synthase may be in higher concentrations.
Todd et al. suggested that exercise intensities below 70%
of VO2max may not be suﬃcient to stimulate signiﬁcant
alterations in TXA2 activity [16]. There has been some
conﬂicting evidence in regards to how exercise inﬂuences
TXA2 concentrations following exercise. Aerobically trained
individuals seem to have an enhanced antioxidant system6 Journal of Aging Research
[29, 31], which could explain the lack of signiﬁcant alter-
ations in TXA2 activity at the low exercise intensity.
Increased risk and incidence of disease are associated
with low aerobic capacity [5]. In the present study, there
was a relationship between aerobic capacity as assessed
by VO2max and exercise-induced PGI2 production in pre-
and stage 1 middle-aged hypertensive African Americans.
African American subjects with lower VO2max had lower
PGI2 formation. Impaired PGI2 production in response
to exercise may be suggestive of endothelial dysfunction.
When racial comparisons are made, the endothelium of
African Americans is closer to the state characteristic for
endothelium-impaired functional disorders than Caucasians
[1]. This may explain, in part, the predisposition of African
Americans to complications associated with cardiovascular
disease.
The middle-aged participants were carefully screened
to provide us with a homogenous population of healthy
participants. The strict inclusion criteria lead to the small
sample size which is a limiting factor of this study. The lack
of signiﬁcance found for the urinary metabolite 11-dTXB2
following the acute exercise bout could be due to the small
sample size and/or the intensity level of the exercise session.
6. Conclusion
William Aird suggests that to develop an understanding
of the endothelium in health and disease, one would have
to look back at the early ancestral environment where the
endothelium evolved to a state of maximal ﬁtness [32]. He
further comments that the endothelium is not adapted to
withstand the rigors of high fat diet, epidemics associated
withhigh-densitypopulations, sedentarylifestyle,oroldage.
The present study examined the most well-characterized
eicosanoids aﬀecting endothelial function in a population of
sedentary, middle-aged pre- and stage 1 hypertensive African
Americans who reside in an urban area. Our preliminary
study showed that those with a lower aerobic capacity had
a diminished capacity to produce PGI2, the cardioprotective
eicosanoid produced by the vascular endothelium, after
exercise. Future studies should examine the eﬀects of long-
term aerobic exercise training and diet change (in order to
mimic ancestral eating habits) on endothelial function in
African American hypertensives.
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